Nina Capital
Nina Capital is a Barcelona-based venture capital firm founded in 2019 that invests exclusively at the intersection of healthcare and technology, writing €200k–€1,500k tickets at pre-seed to seed+ stages. The firm manages three EUVECA funds and has backed 50+ companies across nearly 20 countries.
- Company typePrivate
- Founded2019
- HeadquartersBarcelona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Nina Capital does
Nina Capital is a Barcelona-headquartered venture capital firm founded in 2019 by Marta G. Zanchi that invests exclusively at the intersection of healthcare and information technology. The firm operates as an Alternative Investment Fund Manager (AIFM) authorized and regulated by Spain's CNMV (Comisión Nacional del Mercado de Valores), managing three European Venture Capital Funds (EUVECAs): Fund I FCRE (2019 vintage, fully subscribed), Fund II FCRE (2021 vintage, fully subscribed), and Fund III FCRE (2025 vintage, currently in LP placement). It does not develop proprietary technology products; rather, it deploys LP capital into pre-seed to seed+ healthcare technology companies, writing tickets of €200k to €1,500k and operating as a lead or co-investor.
Nina Capital's business model is fund management revenue: the firm earns management fees on committed capital across its three vehicles, with carried interest on fund returns as the secondary value driver. Its "customers" are dual — portfolio companies (50+ invested since inception across nearly 20 countries) receive capital, strategic guidance, and access to the Founder & Partner Network; limited partners receive exposure to a specialized healthtech venture portfolio. The firm explicitly excludes drugs and vaccines from its thesis, focusing instead on healthcare tools (solutions helping healthcare organizations improve operations) and medical devices (diagnosis, treatment, mitigation, prevention).
The firm's go-to-market is direct origination through its website pitch form, inbound dealflow email, and a curated network of 9 full-time investment professionals spanning 12 nationalities. Core partnerships with WSGR, Google Cloud, NVIDIA, Microsoft (Azure), and AWS Activate provide portfolio companies with legal counsel, cloud credits, and AI/compute infrastructure — material differentiators versus generalist seed investors. Investment scope is Pan-European, United States, Israel, Canada, and Australia, supported by offices in Barcelona (HQ) and Palo Alto (US). Headcount is small (9 full-time) but operating leverage is meaningful given the fund-based revenue model.
Nina Capital firmographics
Firmographics- Name
- Nina Capital
- Legal name
- NINA CAPITAL SGEIC, S.A.
- Website
- https://nina.capital
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Nina Capital is a Barcelona-based venture capital firm founded in 2019 that invests exclusively at the intersection of healthcare and technology, writing €200k–€1,500k tickets at pre-seed to seed+ stages. The firm manages three EUVECA funds and has backed 50+ companies across nearly 20 countries.
- Ownership category
- akta.pro rank
Nina Capital industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
- akta.pro secondary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Nina Capital is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices2 records
Markets served
Nina Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Fund Management: Nina Capital generates returns through managing three European Venture Capital Funds (EUVECAs) - Fund I (2019 vintage), Fund II (2021 vintage), and Fund III (2025 vintage). The firm is an authorized and regulated Alternative Investment Fund Manager (AIFM) by the CNMV in Spain.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Nina Capital product offering
Product offeringCore offering
Nina Capital is a specialized venture capital firm that invests exclusively at the intersection of healthcare and information technology. The firm manages three European Venture Capital Funds (EUVECAs) — Fund I (2019), Fund II (2021), and Fund III (2025) — and deploys pre-seed to seed+ tickets of €200k to €1,500k into need-driven healthcare technology founders. Beyond capital, the firm provides portfolio companies with strategic resources, operational playbooks, and network access through its Founder & Partner Network.
Product overview
Nina Capital is a specialized venture capital firm that does not offer traditional technology products or services. The firm exclusively invests at the intersection of healthcare and technology, supporting need-driven founders from pre-seed to seed+ stages. The firm's investment focus spans healthcare tools (solutions helping healthcare organizations improve their operations) and medical devices (solutions for diagnosis, cure, mitigation, prevention, or treatment of diseases). Nina Capital provides portfolio companies with strategic resources, operational support, and network access through their Founder & Partner Network, including strategic partnerships, operational playbooks, and investor network access. The firm manages three European Venture Capital Funds (EUVECAs): Fund I (2019), Fund II (2021), and Fund III (2025), with ticket sizes ranging from €200k to €1,500k.
Differentiator
Problem solved
Functional benefit
Products and services
- Nina Capital Fund I, FCRE European Venture Capital Fund (EUVECA) launched in 2019 as Nina Capital's inaugural fund vehicle, fully subscribed and used to deploy pre-seed to seed+ tickets of €200k to €1,500k into healthcare technology startups. The fund is offered to Limited Partners (LPs) as a regulated investment vehicle authorized by the CNMV in Spain.
- Nina Capital Fund II, FCRE Second European Venture Capital Fund (EUVECA) managed by Nina Capital, 2021 vintage, fully subscribed and used to continue deploying pre-seed to seed+ tickets into healthcare technology startups. Offered to Limited Partners as a regulated EUVECA investment vehicle.
- Nina Capital Fund III, FCRE Third European Venture Capital Fund (EUVECA) managed by Nina Capital, 2025 vintage, registered with CNMV in 2024 and launched in January 2025. Currently in its LP placement period, open to Limited Partners, and intended to continue the firm's pre-seed to seed+ healthcare technology investment strategy with ticket sizes of €200k to €1,500k.
Quantifiable outcome
- Invested in 50+ companies across nearly 20 countries since 2019
- +2 more outcomes
Companies that use Nina Capital
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles1 record
Nina Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Nina Capital partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- WSGR (Wilson Sonsini Goodrich & Rosati)coreLegal counsel partner providing legal services and support to Nina Capital's portfolio companies. WSGR has offices in Palo Alto and London, serving as a key advisor for startups in corporate and securities matters.
- Google CloudcoreStrategic partner providing cloud infrastructure and technology services to portfolio companies through Google Cloud's startup programs.
- NVIDIAcoreTechnology partner providing GPU computing resources and AI/ML infrastructure support for portfolio companies developing AI-powered healthcare solutions.
- MicrosoftcoreStrategic partner providing cloud services (Azure), developer tools, and enterprise software access through Microsoft's startup programs.
- Amazon AWS startupscoreTechnology partner providing cloud infrastructure credits and technical support through AWS Activate program for startup portfolio companies.
- OysterminorHR and employment platform partner helping portfolio companies manage global hiring and compliance.
- Ariston GroupminorCommunications and PR partner supporting portfolio companies with marketing and media relations.
- Ballou PRminorPR agency partner providing communications support for portfolio companies.
- AmendolaminorHealthcare-focused PR and communications agency partner for portfolio companies.
- LSI USA _ Europe SummitminorLife Science Intelligence partner providing conference and networking platform for healthcare technology companies.
- RocaJunyentminorSpanish law firm partner providing legal services with Natalia Marti Pico serving on Nina Capital's Board of Directors.
Scale indicators7 records
Recent moves6 records
Expansion highlights3 records
Nina Capital competitors and assessment
Company assessmentDirect peers
- Speedinvest: Speedinvest operates a dedicated Digital Health vertical from Europe and invests at pre-seed to Series A in healthcare/tech startups, making it the closest like-for-like competitor to Nina Capital in stage, geography, and vertical focus.
- Earlybird Venture Capital: Earlybird runs a dedicated health tech fund investing at early stages across Europe, with similar healthcare+technology thesis and ticket sizes to Nina Capital.
- Anthemis: Anthemis is a digital health-focused VC firm that invests in early-stage healthtech startups, sharing Nina's vertical specialization and pre-seed/seed stage orientation.
- Rock Health: Rock Health is a US-based digital health venture fund investing at seed stage in healthcare transformation companies, comparable in vertical focus and early-stage deployment.
- Heal Capital: Heal Capital is a European VC focused on digital health at early stage, with a similar pre-seed to Series A approach and healthcare-only thesis to Nina Capital.
- btov Partners: btov Partners is a European early-stage VC with a digital health vertical and similar ticket sizes, making it directly comparable on stage, geography, and vertical specialization.
- Creandum: Creandum is a leading European early-stage VC that has built health/tech positions, comparable to Nina on stage and regional focus though broader in sector coverage.
Broad incumbents
- Octopus Ventures: Octopus Ventures is a larger UK-based VC with a dedicated health team investing across multiple stages, overlapping with Nina at seed but operating at materially greater scale.
- Andreessen Horowitz (Bio/Health): a16z's bio/health fund invests in healthcare and biology at early stages with much larger check sizes, representing a much larger incumbent pursuing the same vertical thesis.
- HV Capital: HV Capital is a large German/European VC with healthcare exposure at early stages, overlapping with Nina on region and stage but operating as a generalist with greater AUM.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Nina Capital social profiles
Digital presenceNina Capital compliance and trust
Trust signalCompliance1 record
Nina Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nina Capital leadership team
Management profileNumber of profiles
Profiles9 records
Nina Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nina Capital M&A and investment
M&A and investmentM&A
Investments86 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nina Capital
What does Nina Capital do?
Nina Capital is a specialized venture capital firm that invests exclusively at the intersection of healthcare and information technology. The firm manages three European Venture Capital Funds (EUVECAs) — Fund I (2019), Fund II (2021), and Fund III (2025) — and deploys pre-seed to seed+ tickets of €200k to €1,500k into need-driven healthcare technology founders. Beyond capital, the firm provides portfolio companies with strategic resources, operational playbooks, and network access through its Founder & Partner Network.
Is Nina Capital a public or private company?
Nina Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Nina Capital founded?
Nina Capital was founded in 2019. It employs 11 to 50 people.
Where is Nina Capital based?
Nina Capital is headquartered in Barcelona, Spain, in the Europe region.
How does Nina Capital make money?
One revenue line is on record: fund Management.
Who are Nina Capital's main competitors?
Direct peers on record are Speedinvest, Earlybird Venture Capital, Anthemis, Rock Health, Heal Capital, btov Partners and Creandum. Broad incumbents are Octopus Ventures, Andreessen Horowitz (Bio/Health) and HV Capital.
Does Nina Capital have an API?
No public API is recorded for Nina Capital.
What industry is Nina Capital in?
Nina Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.